He was identified as a 2011 MSI Young Scholar by the Marketing Science Institute. The MSI Young Scholar Program selects about 20 of “the most promising University of Michigan. Sunil is an associate professor at the Robert H. Smith School of Business at University of Maryland in the Decision, Operations and Information Technologies Department. Sunil Mithas is a professor in the Robert H. Smith School of Business at the University of Maryland and the author of the book Digital. The MSI Young Scholar Program selects about 20 of 'the most promising. Instituted in 2001, the biennial MSI Young Scholar Program brings together researchers in marketing. MSI Young Scholar Award. Started in 2001, the Marketing Science Institute’s biennial Young Scholar Program brings together some of the most promising scholars in marketing and closely. View Dr Sunil Mithas’ professional profile on LinkedIn. He was identified as a 2011 MSI Young Scholar by the Marketing Science Institute. The MSI Young Scholar Program selects about 20 of 'the most promising 'younger'. Sunil Mithas is a Professor in the Robert H. Smith School of Business at the University of Maryland and the author of the books Dancing. The MSI Young Scholar Program selects about 20 of 'the most promising. Awards & Honors. Marketing. - Faculty & Research. Jill J. Avery. Won a 2. Case Centre Award in the Marketing Category for her case with Thomas Steenburgh and Naseem Dahod, “Hub. Spot: Inbound Marketing and Web 2. HBS Case No. Chung. Finalist for the 2. 975, University Avenue 6713 Colony Drive. University of Wisconsin Madison, WI 53717. Founded in 1961, MSI is a learning organization dedicated to bridging the gap between marketing science theory and business practice. Its biennial Young Scholar Program launched in 2001. John D. Little Award for the best marketing paper published in Marketing Science or Management Science that year. Kasturi Rangan. Winner of the 2. Case Centre Award in the Economics, Politics and Business Environment Category for his case with Sunru Yong, . Avery. Received the 2. MBA Award for Teaching Excellence at Simmons School of Management by vote of the graduating MBA students. Chung. Received a 2. ISMS Doctoral Dissertation Award for “Do Bonuses Enhance Sales Productivity? A Dynamic Structural Analysis of Bonus- Based Compensation Plans” from the INFORMS Society for Marketing Science. Andrade (April 2008) Assistant Professor Marketing Group Haas School of Business – F682. Paper presented at the MSI Fourth Biennial Young Scholar Program, Park City, Utah (January). Chung. Runner- up in 2. Mary Kay Doctoral Dissertation Award from the Academy of Marketing Science. O'Dell Award from the Journal of Marketing Research. Norton. Won a SAGE Young Scholars Award from the Foundation for Personality and Social Psychology in 2. Chung. Received a 2. ISBM Doctoral Support Award for . Norton. Won the 2. Theoretical Innovation Prize from the Society for Personality and Social Psychology for his paper with C. K. Kasturi Rangan. O'Dell Award from the Journal of Marketing Research for . Lehmann and Jennifer Ames Stuart, 2. Norton. Selected with Thomas J. Msi Young Scholar Program OhioSteenburgh for the Marketing Science Institute's 2. Young Scholar Program. The biennial MSI Young Scholar Program brings together some of the most promising scholars in marketing and closely related fields to explore research opportunities and encourage future research collaboration. Lehmann, Journal of Marketing Research, May 1. Green Award from the Journal of Marketing Research for . Srinivasan, and Richard Staelin, Marketing Science, fall 1. Srinivasan, and Richard Staelin, Marketing Science, fall 1. MSI Faculty Scholars. Minority- Serving Institution Faculty Scholars in Cancer Research Awards Neelam Azad, Ph. D, Hampton University, Hampton, Virginia. I am involved in the identification of specific molecular targets and biomarkers for diagnosis and treatment of these diseases. My long- term career goal is to become a successful academician and establish a successful research program dedicated to the investigation of lung pathologies. Chougule, Ph. D, College of Pharmacy, University of Hawaii, Hilo, Hawaii“The long- term goal is to establish the extramurally funded cancer research program; to develop platform targeted nanoparticles for cancer treatment; and involve pharmacy students in cancer research. Professional advancement by achieving tenure and promotion at college to continue my service.”Abstract #3. Biocompatible nanocarrier mediated delivery of STAT- 6 si. RNA to cancer cells. Jonathan Celli, Ph. D, University of Massachusetts Boston, Boston, Massachusetts. Do, Ph. D, Chicago State University, Chicago, Illinois. I am particularly interested in research involving nanotechnology and targeted delivery systems. I have had experience with albumin microsphere and nanosphere delivery systems. I am also interested in examining the stability of pharmaceutical products using various analytical techniques (e. HPLC, DSC). Houston, Ph. D, New Mexico State University, Las Cruces, New Mexico“My long- term career goal is to develop an internationally recognized research program focused on understanding the molecular mechanisms of steroid hormone signaling in cancer cells. Such a program will increase training opportunities in cancer research for both undergraduate and graduate students at New Mexico State University. Iyamu, MD, Meharry Medical College, Nashville, Tennessee. My research is focused on delineating the signaling pathways involved in the progression of lung cancer. I hope to continue with my pursuit of understanding the basis for the progression of cancer, and hope to develop therapies that may be useful in the clinic. I wish to be involved in academia, balancing my time between basic research and spending my time with students so that I can share my passion for science with them. Kim, Ph. D, University of Texas Health Science Center at San Antonio, Edinburg, Texas. Lamango, Ph. D, Florida A& M University, Tallahassee, Florida“My long- range objectives are to continue to engage students in innovative methods in cancer research to effectively tackle and understand the molecular mechanisms by which PMPMEase overexpression/hyperactivity interferes with polyisoprenylated protein signaling pathways leading to cancers. Graduate and undergraduate students will remain an intricate part of the research endeavor as they apply, and learn during the process, novel approaches in seeking solutions to the cancer problem by engaging in one of the current or future research areas in the lab. I will also continue to incorporate up- to- date discoveries, methods and therapeutic approaches in my classroom discussions with Pharm. D students.”Abstract #1. Polyisoprenylated methylated protein methyl esterase as a potential therapeutic target and biomarker in lung cancer. Richard Le. Baron, Ph. D, University of Texas at San Antonio, San Antonio, Texas“My long- range goal is to enrich academic support and opportunities for underrepresented minority individuals seeking to pursue professional training and development in biomedical research generally, and obesity- related diseases in cancer and diabetes specifically.”Abstract #6. Breast cancer biomarkers from biosimulations: transcriptome- to- reactome. My goal is to be an independent funded investigator and establish an urological cancer research program at my institution.”Abstract #6. CCL4 alters migration and induces the expression of alpha smooth muscle actin. Manoj K. Mishra, Ph. D, Alabama State University, Montgomery, Alabama“My long- term career objectives and research goals are to reduce health disparities in cancer and to elucidate the molecular mechanism involved during prostate cancer progression and clearance. Ortiz Martinez, Ph. D, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico“My long- term career goal is to become an R0. Hispanic populations, with a focus on health disparities and cancer prevention and control. In the future, I would also like to be the director of a cancer control and population sciences program at a comprehensive cancer center.”Abstract #2. Factors associated to concurrent anal and cervical HPV infection: Results from a population- based study among Hispanics. Sederick C. Rice, Ph. D, University of Arkansas at Pine Bluff, Pine Bluff, Arkansas“My long- range career objectives are to become a hypothesis- driven, externally funded cancer researcher and study the development and progression of primary tumors into metastatic cancers using translational bioinformatics and pharmacogenomics. My research goals are to use translational bioinformatics to assess the rates of metastasis in primary tumors, correlate treatment therapies that promote the progression of primary tumors into metastatic cancers using translational bioinformatics and pharmacogenomics, and use translational bioinformatics and pharmacogenomics data to develop more effective individualized cancer treatment protocols. Rorie, Ph. D, North Carolina Agricultural and Technical State University, Greensboro, North Carolina“Our lab is interested in finding biomarkers for the triple- negative breast cancer subtype in order to develop targeted therapy and treatment. Saxena, Ph. D, City University of New York Brooklyn College, New York, New York. My goals are also to continue training undergraduates and graduates and develop their interests in basic or translational cancer research through teaching as well as laboratory research experiences. Abstract #4. 88. 1: Nucleolin phosphorylation mediated regulation of gene expression in determining cellular fate during the DNA damage response (DDR). Anil Shanker, Ph. D, Meharry Medical College, Nashville, Tennessee“The long- term goal of the applicant PI's research is to investigate the immune mechanisms of tumor surveillance and rejection and to develop immunotherapy approaches that provide durable clinical benefits in cancer patients including minority populations. Sherif, MD, Ph. D, Howard University, Washington, D. C.“My long- term research goal is to study the biological mechanisms of germ- line mutation and its contribution to carcinogenesis and tumorigenesis in breast cancer. My career goal is, using a translational research approach, to advance the results of cancer research into the clinics. Such a need is especially pressing in neglected communities where patients participate in many clinical and epidemiological research studies but there are no reciprocal medical benefits provided for them except to state that their contributions help humanity in its fight against cancer. My immediate career goal is to secure funding from the NIH and national agencies to support my research and with my advance to independent researcher secure a tenured faculty position. During all these years, I have mostly worked on prostate cancer and the effect of androgen receptor signaling pathway of tumor growth and progression. At this point, I have come with an interesting idea that, if being true, can make an answer to many questions in AR signaling pathway. Right now, I am working on that hypothesis. In addition, I have trained many students and doctors in our lab and I have the major responsibly to be sure that they are highly trained in lab skills. Many of them are involved in cutting- edge cancer research in different institutions all over the world. Beside mentoring and training the students, I have collaborated in five different projects in our lab that are going to be submitted for publication this year.”Abstract #2. Loss of steroid sulfotransferase (SULT) in human prostate cancer: Potential implications for SULT as a biomarker and therapeutic target. Rajeshwar R. Tekmal, Ph. D, University of Texas Health Science Center at San Antonio, San Antonio, Texas“My goal is to take the use of estrogen receptor beta agonist to clinical trials and test their use in endocrine therapy sensitive and resistant breast cancers and as well as identify biomarkers of therapeutic response.”Abstract #6. The estrogen receptor.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
December 2016
Categories |